Imai et al. [95] observed higher LAT1 expression in NSCLC samples without EGFR mutations, which might be associated with TKIs refractoriness and a poor prognosis in combination of LAT1 expression and EGFR wild-type. This evidence concerns the gene EGFR and non-small cell lung carcinoma.